Paxil 20mg
- The recommended dose of paroxetine for social anxiety disorder is 20 mg to 60 mg daily. Those with generalized anxiety disorder usually take 20 mg to 50 mg daily, and those with post-traumatic stress disorder usually take 20 mg a day.
Description
About This Product:
Paxil is the brand name for the antidepressant paroxetine.
Though doctors prescribe Paxil to treat depression, it’s also used to treat anxiety disorders including:
Panic disorder
Social anxiety disorder
Generalized anxiety disorder (GAD)
Post-traumatic stress disorder (PTSD)
Obsessive-compulsive disorder (OCD)
Paxil is also approved by Food and Drug Administration (FDA) to help women manage the hot flashes associated with menopause.
Additionally, doctors may prescribe Paxil off-label to treat conditions other than those for which it has been approved by the FDA.
For example, some doctors prescribe Paxil to treat chronic headaches, and people with diabetes may use the drug to help alleviate tingling in the hands and feet.
Paxil has also been used to treat men who experience premature ejaculation.
A controlled-release form, Paxil CR, can relieve the physical and psychological symptoms some women experience before their menstrual cycle begins each month.
Paxil belongs to a class of antidepressant medications called selective serotonin-reuptake inhibitors (SSRIs).
SSRIs work by boosting levels of serotonin, a neurotransmitter that helps the brain send messages from one nerve cell to another.
Paxil History
GlaxoSmithKline makes Paxil, which the FDA first approved in 2001.
Paxil is also available under the brand names Brisdelle and Pexeva. Generic forms of paroxetine became available in 2003.
GlaxoSmithKline has repeatedly come under fire for its marketing of Paxil and other antidepressants, including accusations that the company misreported data from clinical trials, which showed that Paxil might be unsafe for teenagers and young adults.
In 2012, GlaxoSmithKline agreed to pay a $3 billion fine to U.S. federal prosecutors, in part for its antidepressant marketing practices.
A study published in the medical journal BMJ in 2015 reanalyzed data from 2001 and found that Paxil was ineffective at treating depression in adolescents.
Additionally, the study found that use of the drug among adolescents was associated with significant harm, including thoughts of suicide and suicide attempts.
You must be logged in to post a review.
Reviews
There are no reviews yet.